I noticed that lately the Wall Street Journal Health Blog was a bit light on number of posts being made. At first I thought that not having Ed Silverman and Pharmalot to compete against, the folks at WSJ Health Blog were just being lazy. But now I learn that Scott Hensley is leaving. Here's his farewell post:
A little more than two years ago, I first clicked the publish button on this blog, nervously putting our debut post on the Web. Now, more than 3,900 posts later, I’ve had the pleasure of hitting that button for the last time.You can still follow Scott via Twitter: http://twitter.com/scotthensley
I’m leaving The Wall Street Journal and the blog today. In case you couldn’t tell, it’s been an absolute ball.
The blog launched with high hopes and unknown prospects in March 2007. Happily, from the start the response to our online experiment was extraordinary.
For me, a print reporter turned founding editor of the blog, the thousands of thoughtful reader comments and the kindness of other bloggers have been especially gratifying.
Now I join the ranks of readers of the blog, which I’m confident will carry on just fine without me. If you’d like to stay in touch, the best bet is Twitter, my other fascination.
But what's going to happen to WSJ Health Blog? Scott says the WSJ Blog will do just fine without him. Jacob Goldstein, Scott's partner, is still posting to the blog, but like other blogs that have lost its "founding" pioneer -- notably Pharmalot and CNTO411 -- WSJ Health Blog may be headed toward obscurity. One hint: Scott refers to the blog as an "experiment," which doesn't sound like a business plan destined to survive.